1. Home
  2. DNLI vs TRMD Comparison

DNLI vs TRMD Comparison

Compare DNLI & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • TRMD
  • Stock Information
  • Founded
  • DNLI 2013
  • TRMD 1889
  • Country
  • DNLI United States
  • TRMD United Kingdom
  • Employees
  • DNLI N/A
  • TRMD N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • TRMD Marine Transportation
  • Sector
  • DNLI Health Care
  • TRMD Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • TRMD Nasdaq
  • Market Cap
  • DNLI 2.3B
  • TRMD 2.0B
  • IPO Year
  • DNLI 2017
  • TRMD N/A
  • Fundamental
  • Price
  • DNLI $15.21
  • TRMD $19.47
  • Analyst Decision
  • DNLI Strong Buy
  • TRMD Buy
  • Analyst Count
  • DNLI 15
  • TRMD 1
  • Target Price
  • DNLI $33.50
  • TRMD $23.00
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • TRMD 580.6K
  • Earning Date
  • DNLI 11-05-2025
  • TRMD 11-06-2025
  • Dividend Yield
  • DNLI N/A
  • TRMD 13.35%
  • EPS Growth
  • DNLI N/A
  • TRMD N/A
  • EPS
  • DNLI N/A
  • TRMD 3.31
  • Revenue
  • DNLI N/A
  • TRMD $1,321,800,000.00
  • Revenue This Year
  • DNLI N/A
  • TRMD N/A
  • Revenue Next Year
  • DNLI $95,463.19
  • TRMD N/A
  • P/E Ratio
  • DNLI N/A
  • TRMD $5.88
  • Revenue Growth
  • DNLI N/A
  • TRMD N/A
  • 52 Week Low
  • DNLI $10.57
  • TRMD $13.60
  • 52 Week High
  • DNLI $33.33
  • TRMD $31.44
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 54.76
  • TRMD 34.12
  • Support Level
  • DNLI $15.03
  • TRMD $20.11
  • Resistance Level
  • DNLI $16.51
  • TRMD $20.67
  • Average True Range (ATR)
  • DNLI 0.80
  • TRMD 0.47
  • MACD
  • DNLI 0.11
  • TRMD -0.27
  • Stochastic Oscillator
  • DNLI 61.42
  • TRMD 4.56

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About TRMD TORM plc

TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.

Share on Social Networks: